常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-4.20/0.01
|
|
企業價值
299.86M
|
| 資產負債 |
|
每股賬面淨值
22.09
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
228.61M
|
|
每股收益
15.51
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. |

14.58 
